Thomas C. Popeck, chief executive officer of Henry Schein Products, completed a sale of 1,355 shares of Henry Schein Inc. (NASDAQ: HSIC) on March 19, 2026. The shares traded at $72.79 each, producing proceeds of $98,630. After the disposition, Popeck retained direct ownership of 86,182 shares of the company.
At the time of the transaction, Henry Schein - a health-care distribution company - carries a market capitalization of $8.29 billion and a trailing price-to-earnings ratio of 22.09. According to InvestingPro analysis cited in company coverage, the stock appears to be undervalued at prevailing prices. That same InvestingPro source highlights that company management has been actively repurchasing shares, a dynamic that continued even as the CEO executed this insider sale. Investors are offered further proprietary analysis through an InvestingPro suite that includes additional ProTips and a full Pro Research Report on HSIC.
Separately, Henry Schein reported results for the fourth quarter of 2025 that topped consensus estimates. The company posted earnings per share of $1.34, above the expected $1.30. Revenue in the period reached $3.4 billion, exceeding the forecasted $3.34 billion. Those beats were noted by market observers as evidence of the company’s performance during the latest quarter.
Following a fireside conversation with senior company representatives, Leerink Partners reiterated its Market Perform rating on Henry Schein shares and maintained a $87 price target. The exchange included participation from CFO Ron South as well as investor relations officers Susan Donofrio and Graham Stanley, according to the report accompanying the rating confirmation.
The sequence of events recorded here - a senior executive stock sale, ongoing management buybacks, recent quarterly beats and an affirmed analyst rating - is documented as presented by company filings and analyst commentary. The information available includes the trade details, headline financial results for Q4 2025 and the analyst firm’s published view following its engagement with company executives.
Readers seeking deeper proprietary content about HSIC were directed in the cited coverage to supplemental InvestingPro materials, including seven additional ProTips and a comprehensive research report.